SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Universal Standard Medical Laboratories, Inc.
______________________________________________________________________________
(Name of Issuer)
Common Capital Stock
______________________________________________________________________________
(Title of Class of Securities)
91383910
______________________________________________________________________________
(CUSIP Number)
September 30, 1995
______________________________________________________________________________
(Date of Event Which Requires Filing of this Statement)
Check the following box if a fee is being paid with this statement [ ]. (A
fee is not required only if the filing person: (1) has a previous state-
ment on file reporting beneficial ownership of more than five percent of
the class of securities described in Item 1; and (2) has filed no amendment
subsequent thereto reporting beneficial ownership of five percent or less
of such class.) (See Rule 13d-7).
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE>
CUSIP No.: 48625010
______________________________________________________________________________
1) Names of Reporting Persons S.S. or I.R.S. Identification Nos. of
Above Persons: The Kaufmann Fund, Inc. - TIN #13-2605091
______________________________________________________________________________
2) Check the Appropriate Box if a Member of a Group
(a) N/A
(b)
______________________________________________________________________________
3) SEC Use Only
_______________________________________________________________________________
4) Citizenship or Place of Organization: Maryland
______________________________________________________________________________
Number of (5) Sole Voting Power: 642,500
Shares Bene- ____________________________________________________________
ficially (6) Shared Voting Power: N/A
Owned by ____________________________________________________________
Each Report- (7) Sole Dispositive Power: 642,500
ing Person ____________________________________________________________
With (8) Shared Dispositive Power: N/A
______________________________________________________________________________
9) Aggregate Amount Beneficially Owned by Each Reporting Person:
642,500
______________________________________________________________________________
10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares
_______________________________________________________________
______________________________________________________________________________
11) Percent of Class Represented by Amount in Row 9: 10.04%
______________________________________________________________________________
12) Type of Reporting Person (See Instructions) IV
______________________________________________________________________________
<PAGE>
Item 1(a)
Name of Issuer: Universal Standard Medical Laboratories, Inc.
Item 1(b)
Address of Issuer's Principal Executive Offices: 26500 Northwestern Highway,
Suite 400, Southfield, MI 48075
Item 2(a)
Name of Person Filing: The Kaufmann Fund, Inc.
Item 2(b)
Address of Principal Business Office or, if none, Residence: 140 E. 45th Street
43rd Floor, New York, NY 10017
Item 2(c)
Citizenship: United States
Item 2(d)
Title of Class of Securities: Common Capital Stock
Item 2(e)
CUSIP Number: 91383910
Item 3
If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check
whether the person filing is a:
(a) [ ] Broker of Dealer registered under Section 15 of the Act.
(b) [ ] Bank as defined in section 3(a)(6) of the Act.
(c) [ ] Insurance Company as defined in section 3(a)(19) of the Act.
(d) [X] Investment Company registered under section 8 of the Investment
Company Act.
(e) [ ] Investment Adviser registered under section 203 of the Invest-
ment Advisers Act of 1940.
(f) [ ] Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of
1974 or Endowment Fund; see Section 240.13d-1(b)(1)(ii)(F).
(g) [ ] Parent Holding Company in accordance with Section
240.13d-1(b)(ii)(G) (Note: See Item 7).
(h) [ ] Group, in accordance with Section 240-13d-1(b)(1)(ii)(H).
Item 4
Ownership.
If the percent of the class owned, as of December 31 of the year covered by
the statement, or as of the last day of any month described in Rule 13d-1(b)(2)
if applicable, exceeds five percent, provide the following information as of
that date and identify those shares which there is a right to acquire.
(a) Amount Beneficially Owned: 642,500
(b) Percent of Class: 10.04%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 642,500
(ii) shared power to vote or to direct the vote: N/A
(iii)sole power to dispose or to direct the disposition of: 642,500
(iv) shared power to dispose or to direct the disposition of: N/A
Instruction: For computations regarding securities which represent a
right to acquire an underlying security see Rule 13d-3(d)(1).
Item 5
Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following [ ].
Item 6
Ownership of More than Five Percent on Behalf of Another Person. N/A
Item 7
Identification and Classification of the Subsidiary Which Acquired the Security
Being Reported on By the Parent Holding Company. N/A
Item 8
Identification and Classification of Members of the Group. N/A
Item 9
Notice of Dissolution of Group. N/A
Item 10
Certification.
The following certification shall be included if the statement is filed
pursuant to Rule 13d-1(b):
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in an transaction having
such purposes or effect.
Signature.
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
October 10, 1995
____________________________________
Date
/s/ Anthony W. Toogood
____________________________________
Signature
ANTHONY W. TOOGOOD
VICE PRESIDENT
____________________________________
Name/Title
